Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Advertisement
Lexaria Bioscience Corp.

Lexaria Bioscience Corp. (LEXXW) Stock Overview

Explore Lexaria Bioscience Corp.’s financial performance, market position, analyst ratings, and future outlook.

LEXXW●NASDAQ
HealthcareBiotechnology
$0.001
$0.004(77.36%)
U.S. Market opens in 4h 51m
Advertisement

Lexaria Bioscience Corp. (LEXXW)

Meyka AI Score

Z

Key Financials

Market Cap29.7K
P/E Ratio-1.11
EPS (TTM)$-0.56
ROE-1.90%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

LEXXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lexaria Bioscience Corp. (LEXXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.11 and a market capitalization of 29.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-77.36%
3-Month Change
-97.45%
6-Month Change
-98.91%
Year-to-Date (YTD) Change
-86.81%
1-Year Change
-99.50%
3-Year Change
-99.76%
5-Year Change
-99.95%
All-Time (Max) Change
-99.89%

Contact Information

https://lexariabioscience.com
250 765 6424
740 McCurdy Road, Kelowna, NV, V1X 2P7

Company Facts

70 Employees
CountryUS

Frequently Asked Questions